Early Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy: A Multicenter, Randomized Controlled Trial
This multicenter randomized controlled trial was designed to test the hypothesis that early drain removal (EDR) could decrease the incidence of grade 2 to 4 complications for patients undoing pancreaticoduodenectomy (PD) with low or intermediate risk of postoperative pancreatic fistula (POPF). The s...
Saved in:
Published in | Annals of surgery Vol. 275; no. 2; p. e307 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.02.2022
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | This multicenter randomized controlled trial was designed to test the hypothesis that early drain removal (EDR) could decrease the incidence of grade 2 to 4 complications for patients undoing pancreaticoduodenectomy (PD) with low or intermediate risk of postoperative pancreatic fistula (POPF).
The safety and effects of EDR on postoperative complications after PD are still controversial.
A multicenter randomized controlled trial at 6 tertiary referral hospitals was carried out (NCT03055676). Patients who met the inclusion criteria, including drain amylase level less than 5000 U/L on postoperative day (POD) 1 and POD 3, and drain output less than 300 mL per day within 3 days after surgery, were enrolled. Patients were then randomized to the EDR group or the routine drain removal (RDR) group. In the EDR group, all drainage tubes were removed on POD3. In the RDR group, drainage tubes were removed on POD 5 or beyond. Primary outcome was the incidence of Clavien-Dindo grade 2 to 4 complications. Secondary outcomes were comprehensive complication index, grade B/C POPF, total medical expenses and postoperative in-hospital stay etc, within 90 days after surgery.
A total of 692 patients were screened, and 312 patients were eligible for randomization. Baseline characteristics were well balanced between the 2 groups and 96.8% of these 312 patients had low or intermediate risk of POPF, according to the 10-point fistula risk score. A total of 20.5% of the patients in the EDR group suffered at least 1 grade 2 to 4 complication, versus 26.3% in the RDR group (P = 0.229). Multi-variate analysis showed older age (>65 years old) and blood transfusion were independent risk factors for grade 2 to 4 complications. The rate of grade B/C POPF was low in either group (3.8% vs 6.4%, P = 0.305). The comprehensive complication index of the 2 groups was also comparable (20.9 vs 20.9, P = 0.253). Total medical expenses were not significantly different. Postoperative in-hospital stay was clinically similar (15 days vs 16 days, P = 0.010).
Nearly half of the patients undergoing PD met the inclusion criteria, predicting low incidence of grade B/C POPF and major complications. EDR was safe in these patients but did not significantly decrease major complications. |
---|---|
AbstractList | This multicenter randomized controlled trial was designed to test the hypothesis that early drain removal (EDR) could decrease the incidence of grade 2 to 4 complications for patients undoing pancreaticoduodenectomy (PD) with low or intermediate risk of postoperative pancreatic fistula (POPF).
The safety and effects of EDR on postoperative complications after PD are still controversial.
A multicenter randomized controlled trial at 6 tertiary referral hospitals was carried out (NCT03055676). Patients who met the inclusion criteria, including drain amylase level less than 5000 U/L on postoperative day (POD) 1 and POD 3, and drain output less than 300 mL per day within 3 days after surgery, were enrolled. Patients were then randomized to the EDR group or the routine drain removal (RDR) group. In the EDR group, all drainage tubes were removed on POD3. In the RDR group, drainage tubes were removed on POD 5 or beyond. Primary outcome was the incidence of Clavien-Dindo grade 2 to 4 complications. Secondary outcomes were comprehensive complication index, grade B/C POPF, total medical expenses and postoperative in-hospital stay etc, within 90 days after surgery.
A total of 692 patients were screened, and 312 patients were eligible for randomization. Baseline characteristics were well balanced between the 2 groups and 96.8% of these 312 patients had low or intermediate risk of POPF, according to the 10-point fistula risk score. A total of 20.5% of the patients in the EDR group suffered at least 1 grade 2 to 4 complication, versus 26.3% in the RDR group (P = 0.229). Multi-variate analysis showed older age (>65 years old) and blood transfusion were independent risk factors for grade 2 to 4 complications. The rate of grade B/C POPF was low in either group (3.8% vs 6.4%, P = 0.305). The comprehensive complication index of the 2 groups was also comparable (20.9 vs 20.9, P = 0.253). Total medical expenses were not significantly different. Postoperative in-hospital stay was clinically similar (15 days vs 16 days, P = 0.010).
Nearly half of the patients undergoing PD met the inclusion criteria, predicting low incidence of grade B/C POPF and major complications. EDR was safe in these patients but did not significantly decrease major complications. |
Author | Kleeff, Jorg Lv, Shaocheng Li, Guangming Liu, Rong Liu, Qiaofei Xing, Cheng Yang, Yinmo Liao, Quan Dai, Menghua Zhang, Dongxin Tian, Xiaodong Cao, Feng Tang, Wenbo Ma, Yongsu He, Qiang Li, Fei Guo, Junchao Zhao, Yupei |
Author_xml | – sequence: 1 givenname: Menghua surname: Dai fullname: Dai, Menghua organization: Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, PR China – sequence: 2 givenname: Qiaofei surname: Liu fullname: Liu, Qiaofei organization: Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, PR China – sequence: 3 givenname: Cheng surname: Xing fullname: Xing, Cheng organization: Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, PR China – sequence: 4 givenname: Xiaodong surname: Tian fullname: Tian, Xiaodong organization: Department of General Surgery, Peking University First Hospital, Peking University, Beijing 100034, PR China – sequence: 5 givenname: Feng surname: Cao fullname: Cao, Feng organization: Department of General Surgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China – sequence: 6 givenname: Wenbo surname: Tang fullname: Tang, Wenbo organization: Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing 100853, PR China – sequence: 7 givenname: Shaocheng surname: Lv fullname: Lv, Shaocheng organization: Department of Hepato-Biliary-Pancreatic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, PR China – sequence: 8 givenname: Yongsu surname: Ma fullname: Ma, Yongsu organization: Department of General Surgery, Peking University First Hospital, Peking University, Beijing 100034, PR China – sequence: 9 givenname: Dongxin surname: Zhang fullname: Zhang, Dongxin organization: Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, PR China – sequence: 10 givenname: Jorg surname: Kleeff fullname: Kleeff, Jorg organization: Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, 06120, Halle (Saale), Germany – sequence: 11 givenname: Yinmo surname: Yang fullname: Yang, Yinmo organization: Department of General Surgery, Peking University First Hospital, Peking University, Beijing 100034, PR China – sequence: 12 givenname: Rong surname: Liu fullname: Liu, Rong organization: Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing 100853, PR China – sequence: 13 givenname: Qiang surname: He fullname: He, Qiang organization: Department of Hepato-Biliary-Pancreatic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, PR China – sequence: 14 givenname: Fei surname: Li fullname: Li, Fei organization: Department of General Surgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China – sequence: 15 givenname: Guangming surname: Li fullname: Li, Guangming organization: Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, PR China – sequence: 16 givenname: Junchao surname: Guo fullname: Guo, Junchao organization: Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, PR China – sequence: 17 givenname: Quan surname: Liao fullname: Liao, Quan organization: Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, PR China – sequence: 18 givenname: Yupei surname: Zhao fullname: Zhao, Yupei organization: Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, PR China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34117153$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkN1Kw0AQhRdR7I--gcg8gK27STZpvAu1VSGitBUvyzSZxdVkt2w2Sn0f39OICp2bGc58HDhnwA6NNcTYmeBjwdPkcplnY743UZoGB6wvZDAZCRHxHhs0zSvnIprw5Jj1wkiIRMiwz75m6KodXDvUBhZU23esQDewREXQSY_oNRnfwLP2L5DbD7AO7ownV1Op0RMsdPMGVnWkKRx1eAFz3fi2QshUx-09bNnakgwV3ta7K8jgvq06mX7sLmCBprS1_qQSptZ4Z6uqO1dOY3XCjhRWDZ3-7SF7ms9W09tR_nBzN83yURHI2HdRS5UWKHlapFKgLCcUF0ihCBOpYhRFEJWKc0kbEaUkVBwIjpGIlUwSClEFQ3b-67ttN12-9dbpGt1u_d9X8A3EZHB3 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. |
Copyright_xml | – notice: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1097/SLA.0000000000004992 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 1528-1140 |
ExternalDocumentID | 34117153 |
Genre | Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .-D .XZ .Z2 01R 0R~ 1J1 23M 354 40H 4Q1 4Q2 4Q3 53G 5GY 5VS 6J9 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABPPZ ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACWDW ACWRI ACXJB ACXNZ ADGGA ADHPY AE6 AEBDS AENEX AFCHL AFDTB AFEXH AFSOK AFUWQ AGINI AHJKT AHOMT AHQNM AHVBC AIJEX AINUH AJIOK AJNWD AJZMW AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW ASPBG AVWKF AWKKM AZFZN BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIWNM E.X EBS ECM EEVPB EIF ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IH2 IKREB IKYAY IN~ IPNFZ J5H JF7 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B N9A NPM N~7 N~B O9- OAG OAH OBH OCB ODA ODMTH OGEVE OHH OHYEH OJAPA OL1 OLB OLG OLH OLU OLV OLW OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P RIG RLZ RPM RXW S4R S4S TAF TEORI TSPGW UQX V2I VVN W3M WH7 WOQ WOW X3V X3W XXN XYM YFH YOC ZFV ZY1 ~H1 |
ID | FETCH-LOGICAL-c256t-11df9ca509c951a5d8e6cae31375f6a1c24df005eb149e1f6210a416f577e3af2 |
IngestDate | Wed Oct 16 00:42:04 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c256t-11df9ca509c951a5d8e6cae31375f6a1c24df005eb149e1f6210a416f577e3af2 |
PMID | 34117153 |
ParticipantIDs | pubmed_primary_34117153 |
PublicationCentury | 2000 |
PublicationDate | 2022-02-01 |
PublicationDateYYYYMMDD | 2022-02-01 |
PublicationDate_xml | – month: 02 year: 2022 text: 2022-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Annals of surgery |
PublicationTitleAlternate | Ann Surg |
PublicationYear | 2022 |
SSID | ssj0014807 |
Score | 2.5469592 |
Snippet | This multicenter randomized controlled trial was designed to test the hypothesis that early drain removal (EDR) could decrease the incidence of grade 2 to 4... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | e307 |
SubjectTerms | Aged Device Removal Drainage - instrumentation Female Humans Incidence Male Middle Aged Pancreatic Fistula - epidemiology Pancreatic Fistula - prevention & control Postoperative Complications - epidemiology Postoperative Complications - prevention & control Risk Assessment |
Title | Early Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy: A Multicenter, Randomized Controlled Trial |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34117153 |
Volume | 275 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6lIKFeEIh3Ac2BWzDU6-dyiwpVhUJVaCrlVq33oVhqshWxi-j_4a_wu5h9OLZKi4AcLGvWsqKdLzuPfDNDyKuqpJzRXEaZYjRKeVVFTKEjJ7SqNJrjUjhuzqfD_OAk_TjP5qPRzwFrqW2qN-Ly2rqS_9EqylCvtkr2HzS7eSkK8B71i1fUMF7_Sse-O_F7O-UB92lpLmwHjfX4mGvXCuTI90y1FNdmMZ6ab5Z87lKArl6kUeMvgVh-hLp33qMY76Pe2zM-nrjh4f2Cka3BM8om-ZfffT27K9617M4wP5mvpFnWlzZn7AnwZ3g7s_swdIH7ls3rQUm2S5Y7ZoHl2S7ajbWY1q2Vfq650arupPMwimVvoYLpdVRin82d47PSBHnIaGAwvLthh6hwClMMbWPfx6k7pqmfsBLwSAeHrkr84NzfrIHvMnw8nfguleGDMR4dPo5bdr50CEGLHhexb17859UrPbq7pS2yVZT2nD20OaPwX5Yt2u-KNlnx9rqvs03udK-4Et44N2d2j9wN8QlMPNjuk5FaPSA_HNDAAQ0C0KBegwUaoKgDGligAQINzFcYAg0s0MBo6PEEAWjggAY3AO0dTGAAs9fQgwx6kIED2UNysv9htncQhfkekUBHu0ENS83sSA4m0M_nmSxVLrhK4qTIdM5jQVOp0UqgO5EyFeucxrscAwidFYVKuKaPyK2VWaknBJI0Y0LmDOOfPJUK_Vpd8biUuaAs5rF6Sh77XT09901cTrv9fnbjyg7Z7tH5nNzW-ONQL9AFbaqXTsO_AMbJiYY |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+Drain+Removal+is+Safe+in+Patients+With+Low+or+Intermediate+Risk+of+Pancreatic+Fistula+After+Pancreaticoduodenectomy%3A+A+Multicenter%2C+Randomized+Controlled+Trial&rft.jtitle=Annals+of+surgery&rft.au=Dai%2C+Menghua&rft.au=Liu%2C+Qiaofei&rft.au=Xing%2C+Cheng&rft.au=Tian%2C+Xiaodong&rft.date=2022-02-01&rft.eissn=1528-1140&rft.volume=275&rft.issue=2&rft.spage=e307&rft_id=info:doi/10.1097%2FSLA.0000000000004992&rft_id=info%3Apmid%2F34117153&rft_id=info%3Apmid%2F34117153&rft.externalDocID=34117153 |